These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 9149578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L, Mende CN, Zaidel G, Zwillich CW, Petrocella VJ, Yancey SW, Rickard KA.
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
    Dente FL, Bancalari L, Bacci E, Bartoli ML, Carnevali S, Cianchetti S, Di Franco A, Giannini D, Vagaggini B, Testi R, Paggiaro PL.
    Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
    [Abstract] [Full Text] [Related]

  • 9. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF, Mackay T, Driver H, Douglas NJ.
    BMJ; 1990 Dec 15; 301(6765):1365-8. PubMed ID: 1980220
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.
    Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S, Gratziou C, Holgate ST, Howarth PH.
    Eur Respir J; 1999 Aug 15; 14(2):275-82. PubMed ID: 10515401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
    Pizzichini MM, Kidney JC, Wong BJ, Morris MM, Efthimiadis A, Dolovich J, Hargreave FE.
    Eur Respir J; 1996 Mar 15; 9(3):449-55. PubMed ID: 8730003
    [Abstract] [Full Text] [Related]

  • 16. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
    Lockey RF, DuBuske LM, Friedman B, Petrocella V, Cox F, Rickard K.
    Chest; 1999 Mar 15; 115(3):666-73. PubMed ID: 10084473
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
    Kraft M, Martin RJ, Lazarus SC, Fahy JV, Boushey HA, Lemanske RF, Szefler SJ, Asthma Clinical Research Network.
    Chest; 2003 Jul 15; 124(1):42-50. PubMed ID: 12853500
    [Abstract] [Full Text] [Related]

  • 20. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul 15; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.